Oleamide-mediated sleep induction does not depend on perturbation of membrane homeoviscosity

FEBS Letters

Volumn 463, Issue 3, 1999, Pages 281-284

  Gobbi, Marco ^a   Mennini, Tiziana ^a   Dalla Valle, Fabio ^a   Cervo, Luigi ^a   Salmona, Mario ^a   Diomede, Luisa ^a  

^a Ist Ric Farmacologiche 'Mario N ^*  (Italy)

Author keywords

5 HT(2A) receptor; Membrane homeoviscosity; Oleamide; Oleic acid; Rat; Sleep

Indexed keywords

KETANSERIN; OLEAMIDE; OLEIC ACID; SEROTONIN 1A RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; LOCOMOTION; MALE; MEASUREMENT; MEMBRANE FLUIDITY; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP INDUCTION;

ANIMALS; BRAIN; FLUORESCENCE POLARIZATION; HYPNOTICS AND SEDATIVES; MALE; MEMBRANE FLUIDITY; OLEIC ACID; OLEIC ACIDS; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SLEEP; SYNAPTOSOMES;

ANIMALIA; TRITIUM;

EID: 0033429696     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01630-0     Document Type: Article

References (19)

1. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Boger D.L., Lerner R.A. Science. 268:1995;1506-1509.
2. Guan X., Cravatt B.F., Ehring G.R., Hall J.E., Lerner R.A., Gilula N.B. J. Cell Biol. 139:1997;1785-1792.
3. Huidobro-Toro J.P., Harris R.A. Proc. Natl. Acad. Sci. USA. 93:1996;8078-8082.
4. Thomas E.A., Carson M.J., Neal M.J., Sutcliffe J.G. Proc. Natl. Acad. Sci. USA. 94:1997;14115-14119.
5. Sallanon M., Janin M., Buda C., Jouvet M. Brain Res. 268:1983;95-104.
6. Dugovic C., Wauquier A., Leysen J.E., Janssen P.A. Psychopharmacology. 97:1989;436-442.
7. Pascoe P.A. Pharmacol. Ther. 61:1994;227-236.
8. Lerner R.A. Proc. Natl. Acad. Sci. USA. 94:1997;13375-13377.
9. Heron D.S., Shinitzky M., Hershkowitz M. Proc. Natl. Acad. Sci. USA. 77:1980;7463-7467.
10. Gray E.G., Whittaker V.P. J. Anat. 96:1962;79-87.
11. De Simoni M.G., Giglio R., Dal Toso G., Conforti I., Algeri S. Neuropharmacology. 24:1985;541-545.
12. Shinitzky M., Barenholz Y. Biochim. Biophys. Acta. 515:1978;367-394.
13. Leysen J.E., Niemegeers C.J.E., Van Nueten J.M., Laduron P.M. Mol. Pharmacol. 21:1982;301-314.
14. Basile A.S., Hanus L., Mendelson W.B. NeuroReport. 10:1999;947-951.
15. Cheer J.F., Cadogan A.-K., Marsden C.A., Fone K.C.F., Kendall D.A. Neuropharmacology. 38:1999;533-541.
16. Cadogan A.-K., Fletcher C., Debank P., Marsden C.A., Kendall D.A. Br. J. Pharmacol. 123:1998;2470.
17. Mechoulam R., Fride E., Hanus L., Sheskin T., Bisogno T., DiMarzo V., Bayewitch M., Vogel Z. Nature. 389:1997;25-26.
18. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A. Nature. 384:1996;83-87.
19. Mechoulam R., Fride E., Di Marzo V. Eur. J. Pharmacol. 359:1998;1-18.